FDA NDC Directory · JSON-LD · Markdown

XIFAXAN

NDC 50090-2445 · HUMAN PRESCRIPTION DRUG · TABLET

Generic namerifaximin
Labeler / ManufacturerA-S Medication Solutions
Marketing categoryNew Drug Application (innovator) · App NDA021361
Dosage form / routeTABLET · ORAL
Active ingredientsRIFAXIMIN (200 mg/1)
Marketing started20040725
Package count1

External sources

Source: openFDA. Public-domain (CC0).